Theranexus Stock

Theranexus Debt 2024

Theranexus Debt

-1.26 EUR

Ticker

ALTHX.PA

ISIN

FR0013286259

WKN

A2H6LX

In 2024, Theranexus's total debt was -1.26 EUR, a -70.09% change from the -4.22 EUR total debt recorded in the previous year.

Theranexus Aktienanalyse

What does Theranexus do?

Theranexus SA is a French biotechnology company founded in Lyon in 2013. The company specializes in the development of drugs for the treatment of neurodegenerative diseases. It is one of the few companies specialized in the synthesis of drug candidates through the combination of molecules. The idea to create Theranexus arose from the collaboration between Mathieu Charveriat and Franck Mouthon, two experienced researchers who both worked at the CNRS laboratory at the University of Lyon. Their goal was to synthesize a new class of molecules that are more effective in the treatment of neuropsychiatric disorders such as depression, anxiety, narcolepsy, and Alzheimer's. The company specializes in two main areas: the development of novel drugs and the identification of drug candidates through the modulation of molecules that influence neuronal communication. Theranexus closely collaborates with academic partners to develop a wide range of therapeutic options for neurodegenerative diseases. The company focuses on the development of drugs that work in a unique and seamless way. Theranexus SA has a unique business model in the field of drug development. The company utilizes its innovative technology platform to combine and rearticulate molecules that can influence neuronal communication. The company aims to expand its technology platform and extend its research to other disease areas. The company operates two main activities: the development of drug candidates for the treatment of neurodegenerative diseases and the identification of new drug candidates through the modulation of molecules that influence neuronal communication. The company has recently developed a cathepsin S platform that focuses on the discovery of drugs and drug candidates for the treatment of neurodegenerative diseases. Cathepsin S is an enzyme involved in the formation of amyloid deposits that can play a role in Alzheimer's disease and other neurodegenerative diseases. Theranexus has also developed a platform for the formation of nanoparticles to enable drugs to have a longer half-life and reduce dosage. The company utilizes the platform to stabilize therapeutic molecules by modifying their chemical properties in the body. Theranexus's current products include ANX-368, a drug candidate for the treatment of narcolepsy, and THN102, a combination drug for the treatment of Parkinson's and sleep disorders. The drug candidate TNX-102 is being developed as a potential medication for the treatment of neuropathic pain. Overall, Theranexus SA aims to develop effective and innovative drugs for the treatment of neurodegenerative diseases. The company is committed to expanding its technology platform and continuing its research in other disease areas. Theranexus ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Theranexus's Debt Structure

Theranexus's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Theranexus's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Theranexus’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Theranexus’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Theranexus stock

What is the debt of Theranexus this year?

Theranexus has a debt level of -1.26 EUR this year.

What was the debt of Theranexus compared to the previous year?

The debt of Theranexus has increased by -70.09% compared to the previous year dropped.

What are the consequences of high debt for investors in Theranexus?

High debt can pose a risk for investors of Theranexus, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Theranexus?

Low debt means that Theranexus has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Theranexus affect the company?

An increase in debt of Theranexus can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Theranexus affect the company?

A reduction in debt of Theranexus can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Theranexus?

Some factors that can influence the debt of Theranexus include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Theranexus so important for investors?

The debts of Theranexus are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Theranexus take to change the debt?

To change the debt, Theranexus can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Theranexus pay?

Over the past 12 months, Theranexus paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Theranexus is expected to pay a dividend of 0 EUR.

What is the dividend yield of Theranexus?

The current dividend yield of Theranexus is .

When does Theranexus pay dividends?

Theranexus pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Theranexus?

Theranexus paid dividends every year for the past 0 years.

What is the dividend of Theranexus?

For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Theranexus located?

Theranexus is assigned to the 'Health' sector.

Wann musste ich die Aktien von Theranexus kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Theranexus from 11/1/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 11/1/2024.

When did Theranexus pay the last dividend?

The last dividend was paid out on 11/1/2024.

What was the dividend of Theranexus in the year 2023?

In the year 2023, Theranexus distributed 0 EUR as dividends.

In which currency does Theranexus pay out the dividend?

The dividends of Theranexus are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Theranexus

Our stock analysis for Theranexus Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Theranexus Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.